Synonym
Clobetasone (free base); Clobetasona; Clobetasonum
IUPAC/Chemical Name
21-Chlor-9-fluor-17-hydroxy-16beta-methyl-1,4-pregnadien-3,11,20-trion
InChi Key
XXIFVOHLGBURIG-OZCCCYNHSA-N
InChi Code
InChI=1S/C22H26ClFO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-16,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19-,20-,21-,22-/m0/s1
SMILES Code
C[C@@]1(C2)[C@](C(CCl)=O)(O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)C2=O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
408.89
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Naldi L, Diphoorn J. Seborrhoeic dermatitis of the scalp. BMJ Clin Evid. 2015 May 27;2015:1713. PMID: 26016669; PMCID: PMC4445675.
2: Goustas P, Cork MJ, Higson D. Eumovate (clobetasone butyrate 0.05%) cream: a review of clinical efficacy and safety. J Dermatolog Treat. 2003 Jun;14(2):71-85. doi: 10.1080/09546630310004180. PMID: 12775314.
3: Yamamoto Y, Fukami T, Koide T, Onuki Y, Suzuki T, Metori K, Katori N, Hiyama Y, Tomono K. Comparative pharmaceutical evaluation of brand and generic clobetasone butyrate ointments. Int J Pharm. 2014 Mar 10;463(1):62-7. doi: 10.1016/j.ijpharm.2013.12.054. Epub 2014 Jan 7. PMID: 24406671.
4: Williamson J, Eilon LA, Walker SR. Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure. Trans Ophthalmol Soc U K. 1981;101(1):27-9. PMID: 6764318.
5: Lassus A. Clobetasone butyrate and hydrocortisone butyrate in the treatment of eczema: a double-blind comparison. Curr Med Res Opin. 1979;6(3):165-7. doi: 10.1185/03007997909109415. PMID: 391489.
6: Munro DD, Wilson L. Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy. Br Med J. 1975 Sep 13;3(5984):626-8. doi: 10.1136/bmj.3.5984.626. PMID: 1164639; PMCID: PMC1674413.
7: Tsai S, Kageyama N, Warthan M, Cockerell CJ. Acrokeratoelastoidosis. Int J Dermatol. 2005 May;44(5):406-7. doi: 10.1111/j.1365-4632.2005.01980.x. PMID: 15869538.
8: Morley N, Fry L, Walker S. Clinical evaluation of clobetasone butyrate in the treatment of children with atopic eczema, and its effect on plasma corticosteroid levels. Curr Med Res Opin. 1976;4(3):223-8. doi: 10.1185/03007997609109308. PMID: 949903.
9: Eilon LA, Walker SR. Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure. Br J Ophthalmol. 1981 Sep;65(9):644-7. doi: 10.1136/bjo.65.9.644. PMID: 7028089; PMCID: PMC1039614.
10: Debnath SC, Richards AB. Concentration of clobetasone butyrate in aqueous humour. Br J Ophthalmol. 1983 Mar;67(3):203-5. doi: 10.1136/bjo.67.3.203. PMID: 6824626; PMCID: PMC1040009.